Skip to main content

Table 2 Treatment characteristics

From: Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with primary liver cancer: A phase II-study (NCT00356161)

Number of patients 70
Number of treatment cycles 562
 Range 1-34
 Mean 8
Reason for termination of HAI  
 Disease progression (intrahepatic n=11, extrahepatic n=16, both n=17) 44 (63%)
 Chemotherapy-related toxicity 12 (17%)
 Port complication 5 (7%)
 Post-progression HAI 4 (6%)
 Refusal 4 (6%)
 Loss of follow up 1 (1%)
Port complications per patient  
 ≥1 complication 21 (30%)
 ≥3 complications 3 (4%)
 ≥ 1 revision 15 (21%)